Azitra, Inc. SEC filings AZTR
Azitra, Inc. has 237 filings in SEC EDGAR's recent list, going back to Mar 20, 2017. Its latest annual report, Form ARS, was filed on May 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Jun 4, 2026 | — |
| DEFA14A | Additional proxy material | May 27, 2026 | — |
| DEF 14A | Proxy statement | May 8, 2026 | May 8, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 27, 2026 | Apr 27, 2026 |
| DEFA14A | Additional proxy material | Mar 5, 2026 | — |
| DEFA14A | Additional proxy material | Feb 6, 2026 | — |
| DEF 14A | Proxy statement | Jan 2, 2026 | Jan 2, 2026 |
| PRE 14A | Preliminary proxy statement | Dec 23, 2025 | Dec 23, 2025 |
| DEFA14A | Additional proxy material | Jun 18, 2025 | — |
| DEF 14A | Proxy statement | May 29, 2025 | Dec 31, 2024 |
| PRE 14A | Preliminary proxy statement | May 19, 2025 | May 19, 2025 |
| DEFA14A | Additional proxy material | Jan 14, 2025 | — |
| DEF 14A | Proxy statement | Jan 14, 2025 | Jan 14, 2025 |
| PRE 14A | Preliminary proxy statement | Jan 3, 2025 | Jan 3, 2025 |
| DEF 14A | Proxy statement | Oct 9, 2024 | Oct 9, 2024 |
| DEF 14A | Proxy statement | Jun 3, 2024 | Jun 3, 2024 |
| PRE 14A | Preliminary proxy statement | May 24, 2024 | May 24, 2024 |
Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AZTR (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Branford, CT
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1701478
- Former names
- Azitra Inc (until Jan 4, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.